News
US stock futures rose after the Trump administration announced top US officials would meet with their Chinese counterparts ...
U.S.-listed shares of Novo Nordisk are jumping in premarket trading Wednesday even as the Danish pharmaceutical giant lowered ...
Reuters on MSN26m
Obesity drugmaker Novo Nordisk cuts 2025 outlookObesity drugmaker Novo Nordisk NOVOb.CO on Wednesday cut its full-year sales and profit outlook amid lacklustre U.S.
Novo Nordisk on Wednesday managed the unusual feat of seeing its stock price rise after reducing its earnings outlook. But ...
Investing.com -- Novo Nordisk (NYSE: NVO )’s CFO, Karsten Munk Knudsen, expressed doubts on Wednesday about the potential impact of U.S. President Donald Trump’s recent executive order on the ...
Futures on Wall Street are surging after the Trump Administration said that Treasury Secretary Scott Bessent and top trade ...
BAGSVAERD, Denmark (AP) — BAGSVAERD, Denmark (AP) — Novo Nordisk A/S (NVO) on Wednesday reported first-quarter earnings of $4.09 billion. The Bagsvaerd, Denmark-based company said it had profit of 92 ...
Novo Nordisk (NVO, NOVO-B.CO) said first-quarter sales of its first-to-market weight-loss drug Wegovy were 17.36bn Danish ...
Obesity drugmaker Novo Nordisk's CFO said on Wednesday he was sceptical that U.S. President Donald Trump's executive order to ...
Novo Nordisk CFO Karsten Munk Knudsen speaks on Bloomberg Television about earnings, tariffs and the impact of compounding in ...
Obesity drugmaker Novo Nordisk said on Wednesday it would drop gender representation requirements for its U.S. business ...
Novo Nordisk slashed its 2025 sales forecast citing lower-than-expected penetration of its branded GLP-1 weight loss and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results